Post-approval studies (Phase 4)Study completedNCT00373542
What this trial is testing
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
Who this might be right for
Restless Legs Syndrome (RLS)Restless Legs Syndrome
GlaxoSmithKline 39